Literature DB >> 1589451

A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits.

M Mancino1, E Ohia, P Kulkarni.   

Abstract

Cod liver oil administered intramuscularly (0.2 ml/day) lowered intraocular pressure (IOP) of the rabbit from 21 mmHg to 18 +/- 0.4 mmHg (p less than 0.05 n = 8). A higher dose of cod liver oil (1 ml) further lowered intraocular pressure to 14.5 +/- 0.3 mmHg which remained at this level for up to 80 days when the rabbits were sacrificed. Intramuscular injections of liquid lard did not alter IOP in rabbits. When treatment with cod liver oil was stopped, IOP rose to baseline levels. Topical treatment with cyclooxygenase inhibitors had no effect on the IOP lowering effect of cod liver oil. Topical treatment of rabbit eyes with 1% aspirin solution twice daily (up to 28 days) and flurbiprofen t.i.d. (up to 15 days) caused no alteration in the decrease in IOP seen with intramuscular cod liver oil treatment for up to 28 and 15 days respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589451     DOI: 10.1016/0952-3278(92)90120-8

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  4 in total

1.  Phospholipid profiles of control and glaucomatous human aqueous humor.

Authors:  Genea Edwards; Katyayini Aribindi; Yenifer Guerra; Richard K Lee; Sanjoy K Bhattacharya
Journal:  Biochimie       Date:  2014-02-21       Impact factor: 4.079

2.  Cod liver oil: a potential protective supplement for human glaucoma.

Authors:  Wen-Bin Huang; Qian Fan; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

3.  Oral Omega-3 Supplementation Lowers Intraocular Pressure in Normotensive Adults.

Authors:  Laura Elizabeth Downie; Algis Jonas Vingrys
Journal:  Transl Vis Sci Technol       Date:  2018-05-01       Impact factor: 3.283

Review 4.  Rational Basis for Nutraceuticals in the Treatment of Glaucoma.

Authors:  Luigi Antonio Morrone; Laura Rombola; Annagrazia Adornetto; Maria Tiziana Corasaniti; Rossella Russo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.